Loading...

FITC anti-mouse/human CD45R/B220 Antibody FITC anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_FITC
C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
  • RA3-6B2_FITC
    C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103205 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103206 500 µg DKK624
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  2. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  3. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  4. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  5. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  6. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  7. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  8. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  9. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  10. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  11. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  12. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  13. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  14. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  15. Zaman R, et al. 2021. Immunity. :. PubMed
  16. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  17. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  18. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  19. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  20. Israelow B, et al. 2020. bioRxiv. . PubMed
  21. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  22. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  23. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  24. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  25. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  26. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  27. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  28. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  29. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  30. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  31. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  32. Dong L, et al. 2021. Cancer Cell. . PubMed
  33. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  34. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  35. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  36. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  37. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  38. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  39. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  40. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  41. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  42. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  43. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  44. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  45. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  46. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  47. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  48. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  49. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  50. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  51. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  52. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  53. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  54. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  55. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  56. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  57. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  58. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  59. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  60. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  61. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  62. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  63. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  64. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  65. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  66. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  67. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  68. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  69. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  70. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  71. Köchl R, et al. 2020. Elife. 9:00. PubMed
  72. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  73. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  74. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  75. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  76. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  77. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  78. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  79. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  80. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  81. Hutter K, et al. 2020. FEBS J. . PubMed
  82. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  83. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  84. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  85. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  86. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  87. Roy K, et al. 2019. Immunity. 50:616. PubMed
  88. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  89. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  90. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  91. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  92. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  93. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  94. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  95. Li H, et al. 2020. Nature. 584:274. PubMed
  96. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  97. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  98. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  99. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  100. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  101. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  102. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  103. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  104. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  105. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  106. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  107. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  108. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  109. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  110. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  111. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  112. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  113. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  114. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  115. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  116. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  117. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  118. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  119. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  120. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  121. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  122. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  123. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  124. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  125. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  126. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  127. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  128. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  129. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  130. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  131. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  132. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  133. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  134. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  135. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  136. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  137. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  138. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  139. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  140. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  141. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  142. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  143. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  144. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  145. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  146. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  147. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  148. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  149. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  150. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  151. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  152. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  153. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  154. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
  155. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  156. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  157. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  158. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  159. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  160. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  161. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  162. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  163. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  164. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  165. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  166. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  167. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  168. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  169. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  170. Zaman R, et al. 2021. Immunity. :. PubMed
  171. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  172. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  173. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  174. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  175. Israelow B, et al. 2020. bioRxiv. . PubMed
  176. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  177. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  178. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  179. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  180. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  181. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  182. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  183. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  184. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  185. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  186. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  187. Dong L, et al. 2021. Cancer Cell. . PubMed
  188. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  189. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  190. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  191. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  192. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  193. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  194. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  195. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  196. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  197. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  198. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  199. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  200. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  201. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  202. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  203. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  204. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  205. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  206. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  207. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  208. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  209. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  210. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  211. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  212. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  213. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  214. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  215. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  216. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  217. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  218. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  219. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  220. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  221. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  222. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  223. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  224. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  225. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  226. Köchl R, et al. 2020. Elife. 9:00. PubMed
  227. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  228. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  229. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  230. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  231. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  232. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  233. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  234. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  235. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  236. Hutter K, et al. 2020. FEBS J. . PubMed
  237. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  238. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  239. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  240. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  241. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  242. Roy K, et al. 2019. Immunity. 50:616. PubMed
  243. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  244. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  245. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  246. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  247. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  248. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  249. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  250. Li H, et al. 2020. Nature. 584:274. PubMed
  251. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  252. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  253. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  254. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  255. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  256. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  257. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  258. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  259. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  260. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  261. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  262. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  263. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  264. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  265. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  266. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  267. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  268. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  269. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  270. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  271. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  272. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  273. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  274. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  275. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  276. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  277. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  278. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  279. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  280. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  281. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  282. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  283. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  284. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  285. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  286. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  287. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  288. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  289. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  290. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  291. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  292. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  293. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  294. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  295. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  296. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  297. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  298. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  299. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  300. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  301. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  302. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  303. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  304. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  305. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  306. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  307. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  308. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  309. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
  310. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
RRID
AB_312990 (BioLegend Cat. No. 103205)
AB_312991 (BioLegend Cat. No. 103206)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about PTPRC on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F,FC,3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,SB
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC,CyTOF®
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark UV™ 387 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark PLUS UV395™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Fire™ 780 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark YG™ 593 anti-mouse/human CD45R/B220 (Flexi-Fluor™) Antibody RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04/25/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
RA3-6B2_FITC
C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
  • RA3-6B2_FITC
    C57BL/6 mouse splenocytes stained with RA3-6B2 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103205 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103206 500 µg DKK624
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  15. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  2. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  3. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  4. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  5. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  6. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  7. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  8. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  9. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  10. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  11. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  12. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  13. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  14. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  15. Zaman R, et al. 2021. Immunity. :. PubMed
  16. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  17. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  18. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  19. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  20. Israelow B, et al. 2020. bioRxiv. . PubMed
  21. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  22. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  23. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  24. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  25. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  26. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  27. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  28. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  29. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  30. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  31. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  32. Dong L, et al. 2021. Cancer Cell. . PubMed
  33. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  34. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  35. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  36. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  37. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  38. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  39. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  40. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  41. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  42. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  43. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  44. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  45. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  46. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  47. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  48. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  49. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  50. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  51. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  52. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  53. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  54. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  55. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  56. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  57. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  58. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  59. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  60. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  61. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  62. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  63. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  64. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  65. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  66. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  67. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  68. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  69. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  70. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  71. Köchl R, et al. 2020. Elife. 9:00. PubMed
  72. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  73. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  74. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  75. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  76. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  77. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  78. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  79. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  80. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  81. Hutter K, et al. 2020. FEBS J. . PubMed
  82. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  83. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  84. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  85. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  86. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  87. Roy K, et al. 2019. Immunity. 50:616. PubMed
  88. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  89. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  90. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  91. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  92. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  93. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  94. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  95. Li H, et al. 2020. Nature. 584:274. PubMed
  96. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  97. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  98. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  99. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  100. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  101. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  102. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  103. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  104. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  105. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  106. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  107. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  108. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  109. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  110. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  111. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  112. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  113. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  114. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  115. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  116. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  117. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  118. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  119. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  120. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  121. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  122. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  123. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  124. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  125. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  126. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  127. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  128. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  129. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  130. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  131. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  132. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  133. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  134. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  135. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  136. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  137. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  138. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  139. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  140. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  141. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  142. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  143. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  144. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  145. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  146. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  147. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  148. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  149. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  150. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  151. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  152. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  153. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  154. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
  155. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  156. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  157. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  158. Wang B, et al. 2022. EMBO J. 41:e108946. PubMed
  159. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  160. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  161. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  162. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  163. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  164. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  165. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  166. Wang Z, et al. 2023. Mediators Inflamm. 2023:9810733. PubMed
  167. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  168. Zhao J, et al. 2021. Emerg Microbes Infect. 10:913. PubMed
  169. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  170. Zaman R, et al. 2021. Immunity. :. PubMed
  171. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  172. Lunardi A, et al. 2015. Cancer Discovery. 5:550. PubMed
  173. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  174. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  175. Israelow B, et al. 2020. bioRxiv. . PubMed
  176. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  177. Hata E, et al. 2016. Int Immunol. 28: 283 - 292. PubMed
  178. Engel O, et al. 2015. Stroke. 46: 3232 - 3240. PubMed
  179. Kaku H, et al. 2014. J Immunol. 193:5904. PubMed
  180. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  181. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  182. Kim CJ, et al. 2018. Immunity. 49:1034. PubMed
  183. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  184. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  185. Chen X, et al. 2021. Theranostics. 11:4655. PubMed
  186. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  187. Dong L, et al. 2021. Cancer Cell. . PubMed
  188. Ota T, et al. 2013. J Immunol. 191:3179. PubMed
  189. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  190. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  191. Kelly L, et al. 2011. J Immunol. 187:3026. PubMed
  192. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  193. Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  194. Zhu X, et al. 2017. Arch Oral Biol. 10.1016/j.archoralbio.2017.03.010. PubMed
  195. Jones M, et al. 2016. PLoS One. 11: 0157271. PubMed
  196. Wang X, et al. 2016. PLoS Pathog. 12: 1005367. PubMed
  197. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  198. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  199. Ohyagi M, et al. 2021. Nat Commun. 12:7344. PubMed
  200. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  201. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  202. Carbonneau C, et al. 2012. Blood. 119:717. PubMed
  203. Delgado‐Benito V et al. 2018. Molecular cell. 72(4):636-649 . PubMed
  204. Zanotti KJ, et al. 2019. J Immunol. 202:1573. PubMed
  205. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  206. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  207. Huang L, et al. 2017. PLoS Biol.. 10.1371/journal.pbio.2001750. PubMed
  208. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  209. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  210. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  211. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  212. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  213. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  214. Wang Z, et al. 2021. J Virol. 95:e0141421. PubMed
  215. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  216. Wong R, et al. 2020. Immunity. 53(5):1078-1094.e7. PubMed
  217. Nakata T, et al. 2020. Proc Natl Acad Sci U S A. 117:28930. PubMed
  218. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  219. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  220. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  221. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  222. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  223. Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed
  224. Nabar NR, et al. 2022. Autophagy. 18:204. PubMed
  225. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  226. Köchl R, et al. 2020. Elife. 9:00. PubMed
  227. Pang D, et al. 2015. Clin Transl Immunology. 4: e41. PubMed
  228. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  229. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  230. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  231. Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed
  232. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  233. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  234. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  235. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  236. Hutter K, et al. 2020. FEBS J. . PubMed
  237. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  238. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  239. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  240. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  241. St Clair JB, et al. 2017. PLoS One. 12:e0170556. PubMed
  242. Roy K, et al. 2019. Immunity. 50:616. PubMed
  243. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  244. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  245. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  246. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  247. Zhang YN, et al. 2020. EBioMedicine. 56:102819. PubMed
  248. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  249. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  250. Li H, et al. 2020. Nature. 584:274. PubMed
  251. Gu X, et al. 2022. Vaccines (Basel). 10:. PubMed
  252. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  253. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  254. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  255. Wittner J, et al. 2022. Mucosal Immunol. 15:668. PubMed
  256. Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
  257. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  258. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  259. Morrison V, et al. 2015. J Immunol. 195: 105 - 115. PubMed
  260. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  261. Liu R, et al. 2018. Front Immunol. 9:592. PubMed
  262. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  263. Liu J, et al. 2021. Immun Inflamm Dis. 9:299. PubMed
  264. Liu R, et al. 2021. Mol Cell Biol. 41:e0025121. PubMed
  265. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  266. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  267. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  268. Morelli AE, et al. 2020. Cell Rep. 30:3448. PubMed
  269. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  270. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  271. Weng TY, et al. 2018. Sci Rep. 8:8216. PubMed
  272. Zhang C, et al. 2021. J Virol. 95:e0079021. PubMed
  273. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  274. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  275. Hsieh Y, et al. 2014. Infect Immun . 82:2087. PubMed
  276. Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed
  277. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  278. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  279. Nguyen HTT, et al. 2021. PLoS Pathog. 17:e1010026. PubMed
  280. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  281. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  282. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  283. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  284. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  285. Sanchez HN, et al. 2020. Nat Commun. 0.5. PubMed
  286. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  287. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  288. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  289. Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
  290. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  291. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  292. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  293. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  294. Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed
  295. Li K, et al. 2020. Nat Commun. 4.844444444. PubMed
  296. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  297. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  298. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  299. Ota T, et al. 2011. J Exp Med. 208:617. PubMed
  300. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  301. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  302. Pan J, et al. 2022. Front Immunol. 13:812924. PubMed
  303. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  304. Iwanami N, et al. 2020. iScience. 23:101260. PubMed
  305. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  306. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  307. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  308. Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed
  309. Tham SM, et al. 2021. Biomedicines. 9:. PubMed
  310. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
RRID
AB_312990 (BioLegend Cat. No. 103205)
AB_312991 (BioLegend Cat. No. 103206)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about PTPRC on UniProt.org

Other Formats

View All CD45R/B220 Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Cyanine7 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Dazzle™ 594 anti-mouse/human CD45R/B220 RA3-6B2 FC
APC/Fire™ 750 anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 750™ anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-A0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Spark NIR™ 685 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 550 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-B0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
Ultra-LEAF™ Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
APC/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
TotalSeq™-C0103 anti-mouse/human CD45R/B220 RA3-6B2 PG
PE/Fire™ 640 anti-mouse/human CD45R/B220 RA3-6B2 FC
PE/Fire™ 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 594 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F,FC,3D IHC
APC anti-mouse/human CD45R/B220 RA3-6B2 FC
Biotin anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
FITC anti-mouse/human CD45R/B220 RA3-6B2 FC
PE anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 RA3-6B2 FC,CyTOF®,IHC-F,IHC-P,IP,Activ
PE/Cyanine5 anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 488 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Alexa Fluor® 700 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Cyanine5.5 anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 421™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F
Brilliant Violet 570™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 650™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 605™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 785™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Brilliant Violet 510™ anti-mouse/human CD45R/B220 RA3-6B2 FC,IHC-F,SB
Brilliant Violet 711™ anti-mouse/human CD45R/B220 RA3-6B2 FC
Purified anti-mouse/human CD45R/B220 (Maxpar® Ready) RA3-6B2 FC,CyTOF®
Spark Violet™ 538 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 581 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark YG™ 570 anti-mouse/human CD45R/B220 RA3-6B2 IHC-F
PE/Fire™ 810 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark Blue™ 574 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Violet™ 423 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark Red™ 718 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark UV™ 387 anti-mouse/human CD45R/B220 RA3-6B2 FC
Spark PLUS UV395™ anti-mouse/human CD45R/B220 RA3-6B2 FC
PerCP/Fire™ 780 anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC
Spark YG™ 593 anti-mouse/human CD45R/B220 (Flexi-Fluor™) Antibody RA3-6B2 FC
Go To Top Version: 2    Revision Date: 04/25/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account